Ready to get a written estimate?
Share your reports for a free clinical review from the operating specialist.
Get Free ConsultationBone marrow (stem cell) transplant is most often referred to MedTrav for blood cancers and certain inherited blood disorders — replacing the patient's blood-forming cells with healthy ones, either their own (harvested before treatment) or a matched donor's.
Uses the patient's own stem cells, collected and stored before high-dose chemotherapy, then reinfused — common for multiple myeloma and some lymphomas.
Uses a matched donor's cells — typically a sibling or unrelated matched donor — common for leukaemia and certain non-cancerous blood disorders.
High-dose chemotherapy (sometimes with radiation) clears diseased cells before the transplant infusion, tailored to your specific diagnosis.
Diagnosis, blood counts and prior treatment history reviewed to confirm transplant is the right approach.
For allogeneic transplant, family members are HLA-typed; unrelated donor registries are searched if needed.
High-dose chemotherapy (sometimes radiation) clears diseased marrow over several days as an inpatient.
The stem cell infusion itself is similar to a blood transfusion — not a surgical procedure.
2–4 weeks of closely monitored inpatient recovery while blood counts recover and infection risk is managed.
Monitoring continues for months after discharge, coordinated with your home haematologist via tele-consultation.
Figures below are indicative ranges reported across accredited Indian hospitals, for planning purposes only — not a marketed or final price.
| Transplant type | Indicative cost (USD) | Typical hospital stay |
|---|---|---|
| Autologous stem cell transplant | $18,000 – $28,000 | 2–3 weeks |
| Allogeneic transplant (matched sibling donor) | $25,000 – $40,000 | 3–5 weeks |
| Allogeneic transplant (matched unrelated donor) | $30,000 – $45,000 | 3–5 weeks |
What this actually covers, and what it doesn't: Donor search costs (for unrelated donor registries), extended isolation-room stays and complications management can vary the total significantly — MedTrav's estimate is confirmed only after your haematologist reviews your full case.
Based on USD 25,000 and approximate September 2026 exchange rates — these move daily and are shown only as a rough reference. Your written estimate and final invoice are always confirmed in USD; your bank or card network sets the exact conversion at the time you pay.
Most commonly blood cancers (leukaemia, lymphoma, multiple myeloma) and certain non-cancerous blood disorders (thalassemia, aplastic anaemia) — your haematologist confirms whether transplant is indicated based on your specific diagnosis.
Autologous transplant uses the patient's own stem cells (collected and stored before high-dose chemotherapy). Allogeneic transplant uses cells from a matched donor — typically a sibling or matched unrelated donor — and carries different risks and benefits depending on the condition being treated.
Through HLA (human leukocyte antigen) typing — siblings have roughly a 25% chance of being a full match; if no family match is found, international donor registries can sometimes identify an unrelated match.
Typically 3–5 weeks inpatient, covering conditioning chemotherapy, the transplant infusion itself, and the critical early recovery period while blood counts recover and infection risk is highest.
Extended monitoring continues for months, watching for infection, graft-versus-host disease (in allogeneic transplants) and recovery of blood counts — MedTrav coordinates tele-consultation follow-up with your home haematologist.
Share your reports for a free clinical review from the operating specialist.
Get Free ConsultationSee how facilitators, physicians and institutions refer cases into this network.
Become a Referral Partner